The US market spans immunoassays, skin prick tests, component-resolved diagnostics, and molecular testing platforms, so skin tests compete with blood-based and molecular options. Growth drivers include a rising incidence of allergic disease, greater awareness among clinicians and patients, and a shift toward personalized treatment approaches. Skin tests can cause side effects, including rare...